Johan Wedell-wedellsborg - Net Worth and Insider Trading
Johan Wedell-wedellsborg Net Worth
The estimated net worth of Johan Wedell-wedellsborg is at least $69 Million dollars as of 2024-11-05. Johan Wedell-wedellsborg is the Director of Y-mAbs Therapeutics Inc and owns about 4,552,778 shares of Y-mAbs Therapeutics Inc (YMAB) stock worth over $69 Million. Details can be seen in Johan Wedell-wedellsborg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Johan Wedell-wedellsborg has not made any transactions after 2023-12-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Johan Wedell-wedellsborg
Johan Wedell-wedellsborg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Johan Wedell-wedellsborg owns 1 companies in total, including Y-mAbs Therapeutics Inc (YMAB) .
Click here to see the complete history of Johan Wedell-wedellsborg’s form 4 insider trades.
Insider Ownership Summary of Johan Wedell-wedellsborg
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
YMAB | Y-mAbs Therapeutics Inc | 2023-12-11 | director & 10 percent owner |
Johan Wedell-wedellsborg Latest Holdings Summary
Johan Wedell-wedellsborg currently owns a total of 1 stock. Johan Wedell-wedellsborg owns 4,552,778 shares of Y-mAbs Therapeutics Inc (YMAB) as of December 11, 2023, with a value of $69 Million.
Latest Holdings of Johan Wedell-wedellsborg
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
YMAB | Y-mAbs Therapeutics Inc | 2023-12-11 | 4,552,778 | 15.10 | 68,746,948 |
Holding Weightings of Johan Wedell-wedellsborg
Johan Wedell-wedellsborg Form 4 Trading Tracker
According to the SEC Form 4 filings, Johan Wedell-wedellsborg has made a total of 9 transactions in Y-mAbs Therapeutics Inc (YMAB) over the past 5 years, including 5 buys and 4 sells. The most-recent trade in Y-mAbs Therapeutics Inc is the acquisition of 127,549 shares on December 11, 2023, which cost Johan Wedell-wedellsborg around $890,292.
Insider Trading History of Johan Wedell-wedellsborg
- 1
Johan Wedell-wedellsborg Trading Performance
GuruFocus tracks the stock performance after each of Johan Wedell-wedellsborg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Johan Wedell-wedellsborg is 122.39%. GuruFocus also compares Johan Wedell-wedellsborg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Johan Wedell-wedellsborg within 3 months outperforms 4 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Johan Wedell-wedellsborg's insider trading performs compared to the benchmark.
Performance of Johan Wedell-wedellsborg
Johan Wedell-wedellsborg Ownership Network
Ownership Network List of Johan Wedell-wedellsborg
Ownership Network Relation of Johan Wedell-wedellsborg
Johan Wedell-wedellsborg Owned Company Details
What does Y-mAbs Therapeutics Inc do?
Who are the key executives at Y-mAbs Therapeutics Inc?
Johan Wedell-wedellsborg is the director & 10 percent owner of Y-mAbs Therapeutics Inc. Other key executives at Y-mAbs Therapeutics Inc include director & President and Chairman Thomas Gad , Sr. VP and Head of Tech Op Torben Lund-hansen , and Sr. VP and COO Joris Wilms .
Y-mAbs Therapeutics Inc (YMAB) Insider Trades Summary
Over the past 18 months, Johan Wedell-wedellsborg made 5 insider transaction in Y-mAbs Therapeutics Inc (YMAB) with a net purchase of 380,768. Other recent insider transactions involving Y-mAbs Therapeutics Inc (YMAB) include a net sale of 501,251 shares made by Thomas Gad , a net purchase of 380,768 shares made by Biotech Aps Wg , and a net sale of 60,000 shares made by Bo Kruse .
In summary, during the past 3 months, insiders sold 150,000 shares of Y-mAbs Therapeutics Inc (YMAB) in total and bought 0 shares, with a net sale of 150,000 shares. During the past 18 months, 620,366 shares of Y-mAbs Therapeutics Inc (YMAB) were sold and 761,536 shares were bought by its insiders, resulting in a net purchase of 141,170 shares.
Y-mAbs Therapeutics Inc (YMAB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Y-mAbs Therapeutics Inc Insider Transactions
Johan Wedell-wedellsborg Mailing Address
Above is the net worth, insider trading, and ownership report for Johan Wedell-wedellsborg. You might contact Johan Wedell-wedellsborg via mailing address: Rungsted Strandvej 113, Rungsted Kyst G7 2960.